Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Natapong, Kosachunhanun"'
Publikováno v:
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 13 (2020)
This multicenter, longitudinal, descriptive, observational study of T2DM adults in Thailand aimed to assess real-world outcomes of basal insulin (BI) dose titration on glycemic control. Three-hundred and twenty-four patients were recruited and follow
Externí odkaz:
https://doaj.org/article/f15361ec19944f4b925c36ef50944933
Autor:
Ninutcha Paengsai, Gonzague Jourdain, Romanee Chaiwarith, Apichat Tantraworasin, Chureeratana Bowonwatanuwong, Sorakij Bhakeecheep, Tim Roy Cressey, Jean Yves Mary, Nicolas Salvadori, Natapong Kosachunhanun
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Since 2005, Thailand has scaled up one of the largest antiretroviral treatment (ART) programs in South East Asia. Although diabetes mellitus (DM) incidence is increasing in low and middle-income countries, its burden and contribut
Externí odkaz:
https://doaj.org/article/67714026d8cb4ca1a83a90a1bc1a8f14
Autor:
Piranee Kaewbut, Natapong Kosachunhanun, Arintaya Phrommintikul, Dujrudee Chinwong, John J Hall, Surarong Chinwong
Publikováno v:
Medicina, Vol 58, Iss 1, p 63 (2021)
Background and Objectives: Clinical inertia is a key obstacle that leads to suboptimal care in patients with type 2 diabetes mellitus (T2DM). It can occur at any stage of T2DM treatment. However, the effect of clinical inertia on diabetes complicatio
Externí odkaz:
https://doaj.org/article/8ba4cfdc7703420997229fa7ac81bd09
Autor:
Dumnoensun Pruksakorn, Sratwadee Lorsomradee, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jeerawan Klangjorhor, Parunya Chaiyawat, Natapong Kosachunhanun, Jongkolnee Settakorn, Olarn Arpornchayanon
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-7 (2017)
Abstract Background Treatment of recurrent aggressive fibromatosis (AF) following surgical resection is a clinical challenge. Non-steroidal anti-inflammatory drugs (NSAIDs) have been reported to be an effective option for controlling the disease. How
Externí odkaz:
https://doaj.org/article/f288bfa73705420da8afa68594535c74
Autor:
Piranee Kaewbut, Natapong Kosachunhanun, Arintaya Phrommintikul, Dujrudee Chinwong, John J Hall, Surarong Chinwong
Publikováno v:
Medicina, Vol 58, Iss 63, p 63 (2022)
Medicina
Medicina; Volume 58; Issue 1; Pages: 63
Medicina
Medicina; Volume 58; Issue 1; Pages: 63
Background and Objectives: Clinical inertia is a key obstacle that leads to suboptimal care in patients with type 2 diabetes mellitus (T2DM). It can occur at any stage of T2DM treatment. However, the effect of clinical inertia on diabetes complicatio
Autor:
Piranee Kaewbut, Natapong Kosachunhanun, Arintaya Phrommintikul, Dujrudee Chinwong, John J. Hall, Surarong Chinwong
Publikováno v:
Healthcare; Volume 10; Issue 9; Pages: 1673
Patients with type 2 diabetes mellitus (T2DM) can be affected by clinical inertia, leading to abysmal results. Studies on a suitable timeframe for treatment intensification remain scarce—especially outside of developed countries. This study aimed t
Autor:
Worapaka Manosroi, Pichitchai Atthakomol, Mattabhorn Phimphilai, Nipawan Waisayanand, Supawan Buranapin, Natapong Kosachunhanun
Publikováno v:
The Journal of Medical Investigation. 67(1-2):95-101
The ACTH stimulation test is used to diagnose adrenal insufficiency (AI). This study evaluated the diagnostic performance of serum delta cortisol from ACTH stimulation tests and determined appropriate cut-off levels of serum 30-minute delta cortisol
Publikováno v:
Healthcare; Volume 11; Issue 7; Pages: 949
This study aimed to estimate the economic burden of hypoglycemia among people with type 2 diabetes (T2D) treated in a tertiary care setting. An electronic database of the largest university-affiliated hospital in northern Thailand was retrieved from
Autor:
Parinya Chamnan, Swangjit Suraamornkul, Seonghui Choi, Sam Kwon, Chaicharn Deerochanawong, Sung-Rae Kim, Sunun Benjachareonwong, Samroeng Seekaew, Natapong Kosachunhanun, Woo Je Lee, Thongchai Pratipanawatr, Sompongse Suwanwalaikorn, Young Min Cho, Tae Keun Oh, Eun Seok Kang, Moon Kyu Lee, Thanitha Sirirak, Sarinya Sattanon
Publikováno v:
Diabetes, Obesity and Metabolism. 22:123-127
The objective of this study was to evaluate the efficacy and safety of gemigliptin added to a stable dose of insulin alone or of insulin in combination with metformin in patients with type 2 diabetes mellitus. After a two-week run-in period, patients
Autor:
Unchalee Permsuwan, Chaicharn Deerochanawong, Pitthaporn Chotikanokrat, Arvind Vilas Gadekar, Natapong Kosachunhanun
Publikováno v:
ClinicoEconomics and Outcomes Research. 11:423-430
Aim Liraglutide, a once-daily subcutaneous glucagon-like peptide-1 (GLP-1) agonist, is approved for treatment of hyperglycemia in patients with type 2 diabetes mellitus (T2DM). For patients with established cardiovascular diseases, liraglutide has al